摘要
目的:探讨代谢综合征(MS)合并阻塞性睡眠呼吸暂停低通气综合征(OSAS)时血脂的改变和意义。方法:以就诊于承德医学院附属医院的MS患者为研究对象,均行睡眠监测,其中单纯MS患者200例,MS合并OSAS患者265例。分别检测两组患者的体重指数(BMI)、颈围、腰围、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)和Epworth睡眠评价量表(ESS)评分。结果:MS+OSAS组患者的BMI、颈围、腰围、TG、TC、LDL-C明显高于MS组,HDL-C明显低于MS组(P<0.05)。MS+OSAS组患者,随着阻塞程度的加重,ESS评分逐渐升高(P<0.05)。结论:MS合并OSAS时可进一步加重血脂的改变;ESS评分可反映OSAS严重程度,积极治疗OSAS亦是预防心血管疾病的重要环节。
Objective: To investigate the changes and significance of blood lipid in metabolic syndromes (MS) combined obstructive sleep apnea hypopnea syndrome (OSAS) patients.Methods: The body weight index (BMI), neck circumference, waist circumference, triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL-C), low density lipoprotein (LDL-C) and ESS score of 200 MS patients and 265 MS+OSAS patients that were treated in the Afifliated Hospital of Chengde Medical College and monitored by polysomnography were measured and recorded respectively. Results:The BMI, neck circumference, waist circumference, TG, TC and LDL-C of MS+OSAS patients were obviously higher than MS patients (P〈0.05); but HDL-C was obviously lower (P〈0.05). For MS+OSAS patients, the ESS score gradually increased as the degree of obstruction.Conclusions: MS combined OSAS can increase the changes of blood lipid;ESS score may relfect the severity of OSAS, active treatment of OSAS is also an important part for preventing cardiovascular disease.
出处
《承德医学院学报》
2015年第3期201-203,共3页
Journal of Chengde Medical University
基金
承德市科学技术研究与发展指导计划(200721069)